Previous 10 | Next 10 |
2024-01-10 12:09:02 ET More on Regeneron Pharmaceuticals Regeneron Pharmaceuticals Inc. (REGN) 42nd Annual JPMorgan Healthcare Conference - (Transcript) Why I Expect Regeneron To Keep Delivering For Investors In 2024 (Upgrade) Regeneron Pharmaceuticals Inc. (REGN) Am...
2024-01-10 08:30:36 ET NetworkNewsWire Editorial Coverage New York, NY – January 10, 2024 – On Sept. 20, 2019, history was made when the U.S. Food and Drug Administration approved Rybelsus as the first oral glucagon-like peptide-1 (GLP-1) agonist for type 2 dia...
2024-01-10 05:51:00 ET Skyrocketing 59%. Reaching a market cap of over $550 billion. Vaulting past Johnson & Johnson to become the biggest pharmaceutical company on the planet. No matter how you look at it, 2023 was a pivotal year for Eli Lilly (NYSE: LLY) . It might see...
2024-01-09 21:35:22 ET Eli Lilly and Company (LLY) JPMorgan 42nd Annual Healthcare Conference January 9, 2024 16:15 ET CorporateParticipants Dave Ricks - Chairman and Chief Executive Officer ConferenceCall Participants Chris Schott - JPMorgan Presentati...
2024-01-09 14:52:04 ET Shares of contract manufacturer Catalent ( NYSE: CTLT ) traded higher on Tuesday to reach the highest level in more than four months after its CEO, Alessandro Maselli, highlighted the company’s production capacity related to GLP-1 class of weight loss d...
2024-01-09 11:40:35 ET More on Madrigal, Viking, etc. Madrigal Pharmaceuticals: A Deeper Look At A Looming NASH Play Viking: Results From 2 Clinical Trials Of Weight Loss Drug Ahead, Other Catalysts On Tap Madrigal Pharmaceuticals: Preparing For Resmetirom's Commerci...
2024-01-08 14:07:33 ET More on Eli Lilly Profiting From Obesity Drugs HRTS, Novo Nordisk And Eli Lilly Eli Lilly: Consider Cutting Before The Southbound Train Leaves (Rating Downgrade) Eli Lilly: Long Path To A Trillion Alphabet unit inks deals with Eli Lilly...
2024-01-08 12:53:29 ET Summary Large pharma stocks, including Johnson & Johnson, may be experiencing a shift in favor as investors move away from glamour growth stocks as 2024 gets underway. Johnson & Johnson is a leading global healthcare company with a below-market valua...
2024-01-08 11:19:33 ET More on Alphabet Google: Don't Be Too Late To The Party! Google: It Warrants A Large Allocation Google: Time To Load Up (Upgrade) Apple, Alphabet, Broadcom, Nvidia CEOs to meet with EU antitrust chief next week Pinterest and Sna...
2024-01-08 08:31:52 ET Summary The healthcare sector was flat in 2023 year as a result of some unique issues. Drug price regulation will be a serious challenge for the sector this year. Defensive healthcare industry groups should do well during the first half and biotechnology...
News, Short Squeeze, Breakout and More Instantly...
2024-07-30 07:07:00 ET If your portfolio doesn't have exposure to the biopharma businesses pursuing the development of weight loss medicines, it might be time to consider changing that situation. With an influx of new drugs for sale, and many competitors looking to secure their share of the...
2024-07-30 05:48:00 ET Going into 2024, DexCom 's (NASDAQ: DXCM) shares were up a whopping 14 times over the last 10 years. The company's continuous glucose monitoring (CGM) devices enjoyed tremendous demand from individuals with diabetes. However, last week was the worst for De...
2024-07-29 15:13:21 ET Eli Lilly & Co (NYSE: LLY) has recently experienced a dramatic $123 billion decline in market value. This significant drop follows positive developments from competitors, notably Viking Therapeutics Inc and Roche Holding AG, who made announcements regarding th...